Molecular mechanisms of heptaplatin effective against cisplatin-resistant cancer cell lines: less involvement of metallothionein期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Molecular mechanisms of heptaplatin effective against cisplatin-resistant cancer cell lines: less involvement of metallothionein

Authors:	Cheol-Hee?Choi,Yoon-Jung?Cha,Chun-San?An,Kyung-Jong?Kim,Kweon-Cheon?Kim,Sung-Pyo?Moon,Zang?Hee?Lee,Young-Don?Min author-information" > author-information__contact u-icon-before" > mailto:ydmin@chosun.ac.kr" title=" ydmin@chosun.ac.kr" itemprop=" email" data-track=" click" data-track-action=" Email author" data-track-label=" " >Email author

Affiliation:	(1) Research Center for Resistant Cells, Department of Pharmacology, Chosun University Medical School, 375 Seosuk-dong, Dong-gu, Gwangju, 501-759, South Korea;(2) Department of Surgery, Chosun University Medical School, 375 Seosuk-dong, Dong-gu, Gwangju, 501-759, South Korea;(3) Department of Cell and Developmental Biology, College of Dentistry, Seoul National University, 110-747, South Korea

Abstract:	Background Heptaplatin is a new platinum derivative with anticancer activity against various cancer cell lines, including cisplatin-resistant cancer cell lines (Cancer Chemother Pharmacol 1995; 35: 441).

Keywords:
本文献已被 PubMed SpringerLink 等数据库收录！